Khalid Abulaban

613 total citations
14 papers, 257 citations indexed

About

Khalid Abulaban is a scholar working on Rheumatology, Epidemiology and Nephrology. According to data from OpenAlex, Khalid Abulaban has authored 14 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 4 papers in Epidemiology and 3 papers in Nephrology. Recurrent topics in Khalid Abulaban's work include Systemic Lupus Erythematosus Research (11 papers), Liver Disease Diagnosis and Treatment (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Khalid Abulaban is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), Liver Disease Diagnosis and Treatment (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Khalid Abulaban collaborates with scholars based in United States, Canada and United Kingdom. Khalid Abulaban's co-authors include Hermine I. Brunner, Stacy P. Ardoin, Michael Bennett, Prasad Devarajan, Jun Ying, David P. Witte, Marisa S. Klein‐Gitelman, Kelly Rouster‐Stevens, Lori B. Tucker and Brad H. Rovin and has published in prestigious journals such as Arthritis & Rheumatology, Arthritis Care & Research and Lupus.

In The Last Decade

Khalid Abulaban

14 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Khalid Abulaban United States	9	184	114	104	32	30	14	257
Desmond YH Yap Hong Kong	8	181 1.0×	79 0.7×	108 1.0×	49 1.5×	25 0.8×	13	262
Juan Javier Lichauco Philippines	8	284 1.5×	171 1.5×	71 0.7×	22 0.7×	29 1.0×	12	397
María del Mar Ayala Gutiérrez Spain	7	210 1.1×	95 0.8×	92 0.9×	50 1.6×	22 0.7×	12	283
Diana Castillo‐Martínez Mexico	11	125 0.7×	63 0.6×	74 0.7×	12 0.4×	44 1.5×	17	245
Shirley King Yee Ying China	8	221 1.2×	136 1.2×	27 0.3×	19 0.6×	38 1.3×	14	263
Karoline Lerang Norway	8	210 1.1×	147 1.3×	33 0.3×	25 0.8×	21 0.7×	18	286
Michelle Trevisin Australia	8	143 0.8×	86 0.8×	96 0.9×	18 0.6×	57 1.9×	9	401
Sara Croca United Kingdom	8	277 1.5×	208 1.8×	58 0.6×	26 0.8×	23 0.8×	13	343
Ivana Nieto‐Aristizábal Colombia	9	188 1.0×	130 1.1×	31 0.3×	7 0.2×	28 0.9×	32	295
DD Gladman Canada	12	290 1.6×	192 1.7×	22 0.2×	20 0.6×	23 0.8×	19	341

Countries citing papers authored by Khalid Abulaban

Since Specialization

Citations

This map shows the geographic impact of Khalid Abulaban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Abulaban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Abulaban more than expected).

Fields of papers citing papers by Khalid Abulaban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Abulaban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Abulaban. The network helps show where Khalid Abulaban may publish in the future.

Co-authorship network of co-authors of Khalid Abulaban

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Abulaban. A scholar is included among the top collaborators of Khalid Abulaban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Abulaban. Khalid Abulaban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Cunningham, Natoshia R., Sarah I. Mossad, Khalid Abulaban, et al.. (2023). A multi-site pilot randomized clinical trial of the Treatment and Education Approach for Childhood-onset Lupus (TEACH) program: study design and COVID-19 adaptations. Pediatric Rheumatology. 21(1). 61–61. 2 indexed citations

Kessler, Elizabeth A., et al.. (2023). Disseminated Ureaplasma polyarthritis in a renal transplant recipient. Pediatric Transplantation. 27(5). e14538–e14538. 1 indexed citations

Ross, Elizabeth A., Khalid Abulaban, Elizabeth A. Kessler, & Natoshia R. Cunningham. (2022). Non-pharmacologic therapies in treatment of childhood-onset systemic lupus erythematosus: A systematic review. Lupus. 31(7). 864–879. 6 indexed citations

Abulaban, Khalid, et al.. (2021). A descriptive study on multisystem inflammatory syndrome in children in a single center in West Michigan. Pediatric Rheumatology. 19(1). 172–172. 10 indexed citations

Brunner, Hermine I., Michael Bennett, Gaurav Gulati, et al.. (2017). Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults. The Journal of Rheumatology. 44(8). 1239–1248. 41 indexed citations

Oni, Louise, Michael W. Beresford, David P. Witte, et al.. (2017). Inter-observer variability of the histological classification of lupus glomerulonephritis in children. Lupus. 26(11). 1205–1211. 23 indexed citations

Abulaban, Khalid, Ndate Fall, Ravi S. Nunna, et al.. (2016). Relationship of cell-free urine MicroRNA with lupus nephritis in children. Pediatric Rheumatology. 14(1). 4–4. 16 indexed citations

Gulati, Gaurav, Martin R. Bennett, Khalid Abulaban, et al.. (2016). Prospective validation of a novel renal activity index of lupus nephritis. Lupus. 26(9). 927–936. 25 indexed citations

Abulaban, Khalid, Huijuan Song, Paul L. Kimmel, et al.. (2016). Predicting decline of kidney function in lupus nephritis using urine biomarkers. Lupus. 25(9). 1012–1018. 29 indexed citations

10.

Brunner, Hermine I., Michael Bennett, Khalid Abulaban, et al.. (2015). Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults. Arthritis Care & Research. 68(7). 1003–1011. 55 indexed citations

11.

Mina, Rina, Khalid Abulaban, Marisa S. Klein‐Gitelman, et al.. (2015). Validation of the Lupus Nephritis Clinical Indices in Childhood‐Onset Systemic Lupus Erythematosus. Arthritis Care & Research. 68(2). 195–202. 27 indexed citations

12.

Abulaban, Khalid & Hermine I. Brunner. (2014). Biomarkers for Childhood-Onset Systemic Lupus Erythematosus. Current Rheumatology Reports. 17(1). 471–471. 17 indexed citations

13.

Abulaban, Khalid, Michael Bennett, Jun Ying, et al.. (2014). A78: Urine Biomarkers Role in Predicting the Future Development of Renal Functional Loss With Lupus Nephritis in Children and Adults. Arthritis & Rheumatology. 66(S3). 3 indexed citations

14.

Abulaban, Khalid, Ndate Fall, Shannen Nelson, et al.. (2014). MicroRNA's role as biomarkers of lupus nephritis in children. Pediatric Rheumatology. 12(S1). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact